David C D Hope

Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial

J. Minnion, K. Alexiadou, Sirazum Choudhury, 2024, Diabetes, obesity & metabolism.